![](/img/cover-not-exists.png)
The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent model
Puig-Saus, C, Laborda, E, Rodríguez-García, A, Cascalló, M, Moreno, R, Alemany, RVolume:
21
Language:
english
Journal:
Cancer Gene Therapy
DOI:
10.1038/cgt.2013.85
Date:
February, 2014
File:
PDF, 471 KB
english, 2014